Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Tool Predicts Post-Therapy Barrett’s Esophagus Recurrence

By HospiMedica International staff writers
Posted on 10 Apr 2026

Barrett’s esophagus (BE) is the only known precursor to esophageal adenocarcinoma, an aggressive cancer with high mortality. More...

After endoscopic eradication therapy, disease can recur, making long-term surveillance essential yet imprecise. Uniform follow-up schedules may expose low-risk patients to unnecessary procedures while missing early relapse in high-risk patients. To help address this challenge, U.S. researchers have developed an artificial intelligence tool to predict recurrence and estimate its timing.

Developed by investigators from the University of Colorado Anschutz Medical Campus (Aurora, Co), USA) and collaborators across the United States, the machine-learning model analyzes routine clinical variables from patients treated with endoscopic eradication therapy. The study reporting the tool’s development and validation appears in Clinical Gastroenterology and Hepatology, published April 7, 2026. The aim is to support risk-aligned surveillance after therapy for Barrett’s esophagus–related dysplasia and early esophageal adenocarcinoma.

Researchers assembled data from more than 2,500 patients who underwent endoscopic eradication therapy and were followed over time to determine whether Barrett’s tissue, dysplasia, or cancer returned and when. The model was trained to evaluate multiple factors simultaneously, including age, body weight, extent of Barrett’s segment, need for additional treatment sessions, and severity of histologic changes at diagnosis. It learned patterns across these variables that are not easily recognized by clinicians.

Nearly three in 10 patients experienced recurrence after successful treatment, and recurrence typically occurred about two years after therapy. In testing, the model achieved over 90% accuracy in identifying patients likely to recur and in estimating the timing of recurrence. Performance held when evaluated both on patients similar to those in the training cohort and on different patient groups drawn from other sources.

Such predictions could enable personalized follow-up that intensifies endoscopic surveillance for those at higher risk and reduces procedure burden for those at lower risk. A risk-aligned approach could also lessen patient anxiety and improve allocation of endoscopy resources. The tool is positioned as an adjunct to existing post-therapy care pathways.

Planned work will further validate the model using international datasets through collaborations in the Netherlands, the United Kingdom, Belgium, and Switzerland. The goal is to confirm generalizability so the model can be applied broadly. If validated, the approach could offer a reliable, universal aid to guide surveillance after endoscopic eradication therapy for Barrett’s esophagus.

“Early detection of Barrett's esophagus related dysplasia and associated esophageal adenocarcinoma can save lives. Identifying recurrence in the form of BE, BE-related dysplasia and BE-related esophageal adenocarcinoma earlier, especially in high-risk patients who have undergone endoscopic eradication therapy, creates opportunities for timely treatment before cancer develops or progresses,” said Sachin Wani, MD, executive director, Rady Esophageal and Gastric Center of Excellence, University of Colorado Anschutz Cancer Center.

Related Links
University of Colorado Anschutz Cancer Center


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.